ArticleInternational journal of nanomedicine2026
Harnessing
Article in International journal of nanomedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Green synthesis of silver nanoparticles (AgNPs) using probiotic microorganisms has emerged as a sustainable strategy for producing multifunctional nanomaterials with enhanced biomedical potential. In the present study, the probiotic bacterium Methods: Nanoparticle formation was initially confirmed by a characteristic color change and subsequently characterized using ultraviolet-visible (UV-Vis) spectroscopy, Fourier transform infrared spectroscopy (FTIR), transmission electron microscopy (TEM), selected area electron diffraction (SAED), and zeta potential analysis. The biological activities of the biosynthesized AgNPs were evaluated through 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging antioxidant assay, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) cytotoxicity assay, in vitro scratch wound-healing assay, and anticoagulant assays based on prothrombin time (PT) and activated partial thromboplastin time (APTT). Results: UV-Vis spectroscopy revealed a distinct surface plasmon resonance peak at approximately 410 nm, confirming the formation of AgNPs. FTIR analysis demonstrated the involvement of extracellular proteins and polysaccharides in nanoparticle reduction and surface capping, while TEM and SAED analyses showed predominantly spherical, crystalline nanoparticles with sizes ranging from 7 to 55 nm and an average diameter of 27.18 ± 12.7 nm. Zeta potential analysis yielded a value of -2.57 mV, indicating weak electrostatic stabilization; however, FTIR data suggested that colloidal stability was primarily maintained through steric hindrance provided by a biomolecular capping layer derived from Conclusion: Collectively, these findings demonstrate that
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.